ACSS2-Mediated Metabolic-Epigenetic Crosstalk Drives Fulvestrant Resistance and Represents a Novel Therapeutic Target
ACSS2介导的代谢-表观遗传串扰驱动氟维司群耐药性，并代表一种新的治疗靶点
期刊:
影响因子:
doi:10.1101/2025.09.23.678089
Mogol, Ayça N; Yoo, Jin Young; Eve, Alicia Arredondo; Goel, Mahima; Dutton, David J; Schane, Claire P; Lam, Audrey; Dutta, Debapriya; Barnick, Betsy; Erdogan, Eda D; Nelson, Erik R; Grosse-Perdekamp, Maria; Madak Erdogan, Zeynep
